Glibcla MP 5mg/500mg/15mg Tablet

Overview Glibcla MP 5mg/500mg/15mg Tablet

Diabex Trio 5mg/500mg/15mg tablets are classified as antidiabetic medications. This combination therapy is indicated for adult patients with type 2 diabetes mellitus to manage blood glucose levels. Diabex Trio should be administered with food, consistently at the same time daily for optimal efficacy. Dosage is determined by your physician and may be adjusted based on blood sugar monitoring. Continued use is crucial, even with controlled blood sugar, as abrupt cessation can lead to elevated glucose, increasing the risk of kidney complications, vision loss, neuropathy, and limb amputation. This medication complements a comprehensive diabetes management plan that includes a balanced diet, regular physical activity, and weight management as directed by your doctor. The most prevalent adverse effect is hypoglycemia (low blood sugar). Familiarize yourself with hypoglycemia symptoms—sweating, lightheadedness, headache, and tremors—and appropriate countermeasures. Regular meals and readily available fast-acting glucose sources (e.g., sugary snacks, fruit juice) are essential. Alcohol consumption should be minimized due to its potential to exacerbate hypoglycemia. Other possible side effects include altered taste, nausea, diarrhea, abdominal pain, headache, edema, blurred vision, fractures, and upper respiratory infections. Weight gain may occur in some patients. This medication is contraindicated in patients with type 1 diabetes, diabetic ketoacidosis, or severe hepatic or renal impairment. Prior heart conditions should be disclosed to your physician before initiating treatment. Diabex Trio is not recommended during pregnancy or breastfeeding without physician consultation. Regular blood glucose monitoring is necessary, and your doctor may order blood tests to evaluate blood cell counts and liver function.

Uses of Glibcla MP 5mg/500mg/15mg Tablet

Managing type 2 diabetes

Major Benefits of Glibcla MP 5mg/500mg/15mg Tablet:

Administer this medication precisely as your physician directs, adhering to the prescribed dosage and treatment period. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Consume Glibcla MP 5mg/500mg/15mg tablets with food.

Common Side effects of Glibcla MP 5mg/500mg/15mg Tablet:

• Anemia (low number of red blood cells)
• Hypoglycemia (low blood glucose level)
• Diarrhea
• Weight gain
• Headache
• Nausea
• Vomiting
• Blood in urine
• Erectile dysfunction
• Visual disorder
• Abdominal pain

How to use Glibcla MP 5mg/500mg/15mg Tablet:

Consume this medication precisely as prescribed by your physician, adhering to both the dosage and treatment duration. Ingest the entire tablet without chewing, crushing, or breaking it. Glibcla MP 5mg/500mg/15mg Tablets should be administered with a meal.

How Glibcla MP 5mg/500mg/15mg Tablet works:

Glibcla MP 5mg/500mg/15mg tablets combine glibenclamide, metformin, and pioglitazone—three distinct antidiabetic agents—to enhance blood sugar management when single or dual therapies prove insufficient. Glibenclamide, a sulfonylurea, stimulates pancreatic insulin release, thus reducing blood glucose levels. Metformin, a biguanide, acts through a three-pronged approach: decreasing hepatic glucose production, slowing intestinal glucose absorption, and boosting insulin responsiveness. Finally, pioglitazone, a thiazolidinedione, augments insulin sensitivity.

What if you forget to take Glibcla MP 5mg/500mg/15mg Tablet :

Should you forget a Glibcla MP 5mg/500mg/15mg Tablet dose, take it immediately if you remember. Otherwise, if your next dose is imminent, omit the missed dose and resume your usual dosing pattern. Never take a double dose.